Trial Profile
A phase 1 / 2 trial of AMG0001 in patients with primary lymphedema
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 26 Jul 2019
Price :
$35
*
At a glance
- Drugs Beperminogene perplasmid (Primary)
- Indications Lymphoedema
- Focus Therapeutic Use
- Sponsors AnGes
- 25 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Oct 2013 New trial record